Challenge 600

Hauptinformation

  • Handelsname:
  • Challenge 600
  • Darreichungsform:
  • SC Suspensionskonzentrat
  • Verwenden für:
  • Pflanzen
  • Art der Medizin:
  • Agrochemisch

Dokumenten

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Challenge 600
    Schweiz
  • Sprache:
  • Deutsch

Therapeutische Informationen

  • Therapiegruppe:
  • Herbizid

Weitere Informationen

Status

  • Quelle:
  • UFAG - Ufficio federale dell'agricoltura. OFAG - Office fédéral de l'agriculture. BLW - Bundesamt für Landwirtschaft.
  • Zulassungsnummer:
  • F-3871
  • Letzte Änderung:
  • 14-11-2018

Packungsbeilage: zusammensetzung, kinische angaben, nebenwirkungen, wechselwirkungen, dosierung, schwangerschaft, stillzeit

Handelsbezeichnung: Challenge 600

(Parallelimport)

Pflanzenschutzmittelverzeichnis (Stand: 06.11.2018)

Produktkategorie:

Ausl. Bewilligungsinhaber:

Eidg. Zulassungsnummer:

Herbizid

Bayer CropScience SA

F-3871

Stoff(e):

Gehalt:

Formulierungscode:

Wirkstoff: Aclonifen 49.6 % 600 g/l

SC Suspensionskonzentrat

Anwendungen

A

Kultur

Schaderreger/

Wirkung

Dosierungshinweise

Auflagen

Freiland: Dill

Freiland:

Gewürzfenchel

Freiland:

Kümmel

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2.5 l/ha

Anwendung: Im Ansaatjahr. Vorauflauf.

1, 2, 3, 4, 6,

7, 8

Freiland: Dill

Freiland:

Gewürzfenchel

Freiland:

Kümmel

Freiland:

Petersilie

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2.5 l/ha

Anwendung: Im Ansaatjahr. Vorauflauf.

1, 2, 3, 4, 5,

G Erbsen

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 1 l/ha

Anwendung: Nachauflauf.

2, 4, 9

G Erbsen

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2 l/ha

Anwendung: Vorauflauf.

2, 4, 9

G Gemüsezwiebel

[gesät]

Einjährige

Dicotyledonen

Aufwandmenge: 1.33 l/ha

Anwendung: Splitbehandlung: 1. Behandlung

2, 4, 9, 10,

11, 12, 13

A

Kultur

Schaderreger/

Wirkung

Dosierungshinweise

Auflagen

Knoblauch

Schalotten

[gesät]

Speisezwiebel

[gesät]

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

mit 0.33 l/ha im fortgeschrittenen Peitschen- bis

2-Blattstadium (BBCH 10-12), 2. Behandlung

mit 0.33-0.5 l/ha (BBCH12-13), 3. Behandlung

mit 0.5 l/ha (BBCH14).

G Karotten

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2 - 2.5 l/ha

Wartefrist: 70 Tage

Anwendung: Splitbehandlung: 1 - 1.5 l/ha im

Vorauflauf (unmittelbar nach der Saat) plus 1.0

l/ha im Nachauflauf (BBCH 13).

2, 4, 9, 12

G Karotten

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 3 l/ha

Wartefrist: 80 Tage

Anwendung: Vorauflauf.

2, 3, 4, 12

Knoblauch

Schalotten

[gesteckt]

Zwiebeln

[gesteckt]

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 3 l/ha

Anwendung: Vorauflauf.

2, 3, 4, 12,

Knollenfenchel

[gesät]

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2 l/ha

Wartefrist: 90 Tage

Anwendung: Vorauflauf, unmittelbar bis 2 Tage

nach der Saat.

2, 4, 9, 15

Knollenfenchel

[gepflanzt]

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2 l/ha

Wartefrist: 70 Tage

Anwendung: Unmittelbar vor der Pflanzung

2, 4, 9, 15

Freiland:

Koriander

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2.5 l/ha

Anwendung: Nach der Saat, im Vorauflauf.

1, 2, 3, 4, 6,

7, 8

G Freiland:

Kümmel

Einjährige

Dicotyledonen

(Unkräuter)

Aufwandmenge: 2.5 l/ha

Anwendung: Frühjahr. Stadium 13-39 (BBCH).

1, 2, 3, 4, 6,

7, 8

A

Kultur

Schaderreger/

Wirkung

Dosierungshinweise

Auflagen

Einjährige

Monocotyledonen

(Ungräser)

G Linse

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 3 l/ha

Anwendung: Splitbehandlung: 2.0 l/ha im

Vorauflauf plus 1.0 l/ha oder 2 x 0.5 l/ha im

Nachauflauf (3- bis 9-Blattstadium der Kultur).

2, 4, 7, 9,

G Linse

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 3 l/ha

Anwendung: Vorauflauf.

2, 3, 4, 7,

Freiland:

Pastinake

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2.5 l/ha

Wartefrist: 90 Tage

Anwendung: Vorauflauf.

1, 2, 3, 4, 7

G Sellerie

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2 l/ha

Wartefrist: 90 Tage

Anwendung: Nach dem Anwachsen der Kultur.

ca. 7 Tage nach der Pflanzung.

2, 4, 7, 9,

G Topinambur

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2.5 l/ha

Wartefrist: 90 Tage

Anwendung: Vorauflauf. Stadium 00-08

(BBCH).

1, 2, 3, 4, 7

Ackerbohne

Eiweisserbse

Kartoffeln

Sonnenblume

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 2.25 - 3 l/ha

Anwendung: Vorauflauf.

3, 4, 10

F Ackerbohne

Eiweisserbse

Sonnenblume

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

Aufwandmenge: 2 l/ha

Anwendung: Vorauflauf.

4, 9, 16

A

Kultur

Schaderreger/

Wirkung

Dosierungshinweise

Auflagen

(Ungräser)

F Eiweisserbse

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 1 l/ha

Anwendung: Nachauflauf.

4, 9

F Kartoffeln

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 1.5 - 2 l/ha

Anwendung: Vorauflauf.

4, 9, 16

F Lupinen

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 1 - 2 l/ha

Anwendung: Stadium 00-07 (BBCH).

1, 4, 7, 9

F Sorghum

Einjährige

Dicotyledonen

(Unkräuter)

Einjährige

Monocotyledonen

(Ungräser)

Aufwandmenge: 1.5 l/ha

Anwendung: Stadium 00-07 (BBCH).

1, 4, 7, 9

Auflagen und Bemerkungen:

Maximal 1 Behandlung pro Kultur.

Nachfolgearbeiten in behandelten Kulturen: bis 48 Stunden nach Ausbringung des Mittels

Schutzhandschuhe + Schutzanzug tragen.

SPe 3: Zum Schutz von Gewässerorganismen vor den Folgen von Drift eine unbehandelte

Pufferzone von 50 m zu Oberflächengewässern einhalten. Zum Schutz vor den Folgen einer

Abschwemmung eine mit einer geschlossenen Pflanzendecke bewachsene Pufferzone von

mindestens 6 m einhalten. Reduktion der Distanz aufgrund von Drift und Ausnahmen gemäss den

Weisungen des BLW.

Ansetzen der Spritzbrühe: Schutzhandschuhe tragen. Ausbringen der Spritzbrühe:

Schutzhandschuhe + Schutzanzug tragen. Technische Schutzvorrichtungen während des

Ausbringens (z.B. geschlossene Traktorkabine) können die vorgeschriebene persönliche

Schutzausrüstung ersetzen, wenn gewährleistet ist, dass sie einen vergleichbaren oder höheren

Schutz bieten.

Anwendung nur in Kulturen zur Produktion von frischen Kräutern.

Anwendung nur in Kulturen zur Produktion von getrockneten Samen und Früchten.

Bewilligt als geringfügige Verwendung nach Art. 35 PSMV (minor use).

Anwendung nur in Kulturen zur Produktion von teeähnlichen Erzeugnissen oder Gewürzen.

SPe 3: Zum Schutz von Gewässerorganismen vor den Folgen von Drift eine unbehandelte

Pufferzone von 20 m zu Oberflächengewässern einhalten. Zum Schutz vor den Folgen einer

Abschwemmung eine mit einer geschlossenen Pflanzendecke bewachsene Pufferzone von

mindestens 6 m einhalten. Reduktion der Distanz aufgrund von Drift und Ausnahmen gemäss den

Weisungen des BLW.

10.Niedrige Aufwandmenge nur in Tankmischung gemäss den Angaben der Bewilligungsinhaberin.

11.Behandlungen im Abstand von mindestens 7 Tagen.

12.Die angegebene Aufwandmenge entspricht der total bewilligten Menge.

13.Nicht für die Produktion von Frühlings-/Bundzwiebeln verwenden.

14.Keine Anwendung auf Sandböden.

15.Es ist auf das Risiko von vorübergehenden Blattchlorosen unmittelbar nach der Behandlung

hinzuweisen.

16.Nur in Tankmischung gemäss den Angaben der Bewilligungsinhaberin.

Gefahrenkennzeichnungen:

Es gilt die Einstufung und Kennzeichnung der ausländischen Originaletikette..

Zusätzliche Schweizerische Gefahrenkennzeichnungen:

SP 1 Mittel und/oder dessen Behälter nicht in Gewässer gelangen lassen.

Im Zweifelsfall gelten einzig die Originaldokumente der Zulassung. Die Erwähnung eines Produktes,

Wirkstoffes oder einer Firma stellt keine Empfehlung dar und bedeutet nicht, dass sich das Produkt im

Verkauf befindet.

8-1-2019

Antimicrobial resistance

Antimicrobial resistance

Antimicrobial resistance is a major international human and animal health issue, because the emergence and spread of drug-resistant strains of bacteria call into question the efficacy of these treatments in humans and animals alike. Preserving the effectiveness of antibiotics is therefore a genuine public health challenge requiring an integrated approach across all types of medicine, according to the "One Health" concept covering both humans and animals. ANSES has mobilised significant resources to addr...

France - Agence Nationale du Médicament Vétérinaire

17-12-2018

 Occupational health: aiming to take better account of multiple exposure

Occupational health: aiming to take better account of multiple exposure

Workers can potentially be exposed to numerous health risk factors through their occupations. The question of multiple exposure is a major challenge for all those active in the field of occupational health, safety and prevention. As part of the 2016-2020 National Occupational Health Plan, a review of the measures taken by the main players to address the question of multiple exposure in France and abroad is being published today. This work has helped determine the state of knowledge and the issues surroun...

France - Agence Nationale du Médicament Vétérinaire

12-12-2018

Moonstruck Chocolate Co. Issues Allergy Alert On Undeclared Hazelnuts In 4 Oz. Sea Salt Caramels Tumbled In Milk Chocolate

Moonstruck Chocolate Co. Issues Allergy Alert On Undeclared Hazelnuts In 4 Oz. Sea Salt Caramels Tumbled In Milk Chocolate

Moonstruck Chocolate Company of Portland, Oregon is recalling 600/4 oz. bags of Sea Salt Caramels Tumbled In Milk Chocolate, because it may contain undeclared hazelnuts. People who have an allergy or severe sensitivity to hazelnuts run the risk of a serious or life-threatening allergic reaction if they consume this product.

FDA - U.S. Food and Drug Administration

5-12-2018

Public health risks associated with food‐borne parasites

Public health risks associated with food‐borne parasites

Published on: Tue, 04 Dec 2018 Parasites are important food‐borne pathogens. Their complex lifecycles, varied transmission routes, and prolonged periods between infection and symptoms mean that the public health burden and relative importance of different transmission routes are often difficult to assess. Furthermore, there are challenges in detection and diagnostics, and variations in reporting. A Europe‐focused ranking exercise, using multicriteria decision analysis, identified potentially food‐borne ...

Europe - EFSA - European Food Safety Authority Publications

1-12-2018

Safety assessment of the process ‘RecyPET Hungária’, based on RecyPET Hungária technology, used to recycle post‐consumer PET into food contact materials

Safety assessment of the process ‘RecyPET Hungária’, based on RecyPET Hungária technology, used to recycle post‐consumer PET into food contact materials

Published on: Fri, 30 Nov 2018 The EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP) assessed the safety of the recycling process RecyPET Hungária (EU register number RECYC0146). The input is hot caustic washed and dried poly(ethylene terephthalate) (PET) flakes originating from collected post‐consumer PET containers, containing no more than 5% of PET from non‐food applications. The flakes are dried and extruded. The output of the extrusion step is cut into pellets in an underwater...

Europe - EFSA - European Food Safety Authority Publications

20-11-2018

Vijf winnaars van energieneutrale sportprojecten kunnen aan de slag

Vijf winnaars van energieneutrale sportprojecten kunnen aan de slag

Op 20 november zijn de vijf winnaars van de Innovation Challenge Energieneutrale Sportaccommodaties, vanuit het programma Sportinnovator, bekendgemaakt. De innovatieve ideeën voor energiebesparing bij sportaccommodaties hebben groen licht gekregen. Ze ontvangen hiervoor steun van het ministerie van Volksgezondheid, Welzijn en Sport om innovatie in de sport te bevorderen. Onderstaande initiatieven krijgen 100.000 euro om het idee in de praktijk door te voeren.

Netherlands - Ministerie van Volksgezondheid, Welzijn en Sport

8-11-2018

Hazard analysis approaches for certain small retail establishments and food donations: second scientific opinion

Hazard analysis approaches for certain small retail establishments and food donations: second scientific opinion

Published on: Wed, 07 Nov 2018 00:00:00 +0100 In 2017, EFSA published a ‘simplified’ food safety management system (FSMS) for certain small retail establishments (butcher, grocer, baker, fish and ice cream shop) based on the application of prerequisite programme (PRP) criteria. The aim of this opinion was to develop similar FSMSs for other small retail enterprises including retail distribution centres, supermarkets, restaurants (including pubs and other catering activities) and food donation. The latter...

Europe - EFSA - European Food Safety Authority Publications

19-9-2018

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

National dietary survey in 2012‐2016 on the general population aged 1‐79 years in the Netherlands

Published on: Tue, 18 Sep 2018 00:00:00 +0200 During the years 2012‐2016, the Dutch National Food Consumption survey was conducted in the Netherlands. For the survey, a random sample was drawn from consumer panels stratified by age and gender and maintained representative to the population with regard to region, address density and educational level. Complete results were obtained for 4,313 persons (response rate 65%); including toddlers, children, adolescents, adults and elderly. Pregnant or lactating ...

Europe - EFSA - European Food Safety Authority Publications

13-9-2018

Use of next‐generation sequencing in microbial risk assessment

Use of next‐generation sequencing in microbial risk assessment

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Despite the ever increase in rigorous control and monitoring measures to assure safe food along the entire farm‐to‐fork chain, the past decade has also witnessed an increase in microbial food alerts. Hence, research on food safety and quality remain of utmost importance. Complementary, and at least as important, is the necessity to be able to assess the potential microbial risks along the food chain. Risk assessment relies on sound scientific data. Unfortuna...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Risk assessment of antimicrobial resistance along the food chain through culture‐independent methodologies

Risk assessment of antimicrobial resistance along the food chain through culture‐independent methodologies

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Antimicrobial resistance (AMR) represents a major challenge for Public Health and the scientific community, and requires immediate and drastic solutions. Acquired resistance to certain antimicrobials is already widespread to such an extent that their efficacy in the treatment of certain life‐threatening infections is already compromised. To date, the emergence and spread of AMR has been attributed to the use, misuse or indiscriminate use of antibiotics as th...

Europe - EFSA - European Food Safety Authority Publications

11-9-2018

Identification and evaluation of potentially mutagenic and carcinogenic food contaminants

Identification and evaluation of potentially mutagenic and carcinogenic food contaminants

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Heat processing of food gives rise to a plethora of chemical compounds whose toxicological effects are largely unknown. Due to a general lack of experimental toxicological data, assessing the risks associated with the consumption of these substances remains a challenge. Computer models that allow for an in silico prediction of physicochemical and toxicological characteristics, may be able to fill current data gaps and facilitate the risk assessment of toxico...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Joint EFSA and ECDC 2018 workshop on preparedness for a multi‐national food safety/public health incident

Joint EFSA and ECDC 2018 workshop on preparedness for a multi‐national food safety/public health incident

Published on: Tue, 21 Aug 2018 00:00:00 +0200 Abstract In May 2018, EFSA and ECDC co‐facilitated a workshop on preparedness for a multi‐national food safety/public health incident. The workshop, hosted at AGES in Vienna, was conceived to closely align with EFSA's Strategy 2020 commitment to prepare for future risk assessment challenges. EFSA, ECDC, AGES and BfR worked together closely to develop a workshop and associated training materials to be delivered over a 2.5‐day agenda. The workshop was attended...

Europe - EFSA - European Food Safety Authority Publications

29-8-2018

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Safety assessment of the process ‘General Plastic’, based on Starlinger Decon technology, used to recycle post‐consumer PET into food contact materials

Published on: Fri, 10 Aug 2018 00:00:00 +0200 This scientific opinion of the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF Panel) deals with the safety evaluation of the recycling process General Plastic (EU register No RECYC153), which is based on the Starlinger Decon technology. The decontamination efficiency of the process was demonstrated by a challenge test. The input of this process is hot caustic washed and dried poly(ethylene terephthalate) (PET) flakes orig...

Europe - EFSA - European Food Safety Authority Publications

22-8-2018

Dringende Sicherheitsinformation zu UniCel DxH 800/600 Cellular Analysis Systems von Beckman Coulter, Inc.

Dringende Sicherheitsinformation zu UniCel DxH 800/600 Cellular Analysis Systems von Beckman Coulter, Inc.

Weitere Informationen sowie Details zum Produkt entnehmen Sie bitte der anliegenden Kundeninformation des Herstellers.

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

21-8-2018

Dringende Sicherheitsinformation zu Direct Radiography system DX-D 600 von Agfa HealthCare N.V.

Dringende Sicherheitsinformation zu Direct Radiography system DX-D 600 von Agfa HealthCare N.V.

Weitere Informationen sowie Details zum Produkt entnehmen Sie bitte der anliegenden Kundeninformation des Herstellers.

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

20-8-2018

Danish Medicines Agency lands new European chairmanship

Danish Medicines Agency lands new European chairmanship

Nikolai Brun, Director of Medical Evaluation & Biostatistics, has been elected chair of the Task Force on Big Data in the pharmaceutical area. The task force is a collaboration between the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) which is to identify advantages and challenges of using big data for the development of medicine.

Danish Medicines Agency

20-8-2018

Drug and Alcohol Use During Orientation Week

Drug and Alcohol Use During Orientation Week

OTTAWA – For students entering university and colleges across Canada, orientation week is an exciting time to get to know your new school, classmates and roommates. While parties during orientation week are a great way to celebrate, they can present safety challenges, especially when it comes to the use of alcohol and drugs.

Health Canada

27-7-2018

Dringende Sicherheitsinformation zu ARCHITECT c4000 / c8000 / c16000 Processing Module von Abbott Laboratories (Abbott Park)

Dringende Sicherheitsinformation zu ARCHITECT c4000 / c8000 / c16000 Processing Module von Abbott Laboratories (Abbott Park)

Weitere Informationen sowie Details zum Produkt entnehmen Sie bitte der anliegenden Kundeninformation des Herstellers.

Deutschland - BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte

13-12-2018

Efavirenz Teva 600 mg Filmtabletten

Rote - Liste

5-12-2018

Uniphyllin® 300 mg/400 mg/600 mg

Rote - Liste

30-11-2018

.@US_FDA has selected 8 novel medical devices as participants in #FDA’s Innovation Challenge to address the #OpioidEpidemic by preventing and treating opioid use disorder. #FDAInnovationChallenge

.@US_FDA has selected 8 novel medical devices as participants in #FDA’s Innovation Challenge to address the #OpioidEpidemic by preventing and treating opioid use disorder. #FDAInnovationChallenge

. @US_FDA has selected 8 novel medical devices as participants in #FDA’s Innovation Challenge to address the #OpioidEpidemic by preventing and treating opioid use disorder. #FDAInnovationChallenge

FDA - U.S. Food and Drug Administration

20-11-2018

SUSTIVA® 600 mg Filmtabletten

Rote - Liste

12-10-2018

The 2nd week of National Cybersecurity Awareness Month is here! This  week’s theme: “Cybersecurity = A Cross-Cutting Challenge to Tackle  Together”. Learn more about #NCSAM at   https://www.dhs.gov/stopthinkconnect …. #FDA #MedicalDevicespic.twitter.com/H

The 2nd week of National Cybersecurity Awareness Month is here! This week’s theme: “Cybersecurity = A Cross-Cutting Challenge to Tackle Together”. Learn more about #NCSAM at https://www.dhs.gov/stopthinkconnect …. #FDA #MedicalDevicespic.twitter.com/H

The 2nd week of National Cybersecurity Awareness Month is here! This week’s theme: “Cybersecurity = A Cross-Cutting Challenge to Tackle Together”. Learn more about #NCSAM at https://www.dhs.gov/stopthinkconnect …. #FDA #MedicalDevices pic.twitter.com/H3rUbSyLPq

FDA - U.S. Food and Drug Administration

8-10-2018

ISENTRESS® 600 mg Filmtabletten

Rote - Liste

30-9-2018

Today is the last day to submit applications to the #FDAInnovationChallenge. Thanks to all who have applied.  Selected applications will be announced in November. For more information about the challenge, click the link:   https://go.usa.gov/xP4Nk pic.twi

Today is the last day to submit applications to the #FDAInnovationChallenge. Thanks to all who have applied. Selected applications will be announced in November. For more information about the challenge, click the link: https://go.usa.gov/xP4Nk pic.twi

Today is the last day to submit applications to the #FDAInnovationChallenge. Thanks to all who have applied. Selected applications will be announced in November. For more information about the challenge, click the link: https://go.usa.gov/xP4Nk  pic.twitter.com/pFJZ39oGJC

FDA - U.S. Food and Drug Administration

29-9-2018

Reminder: the last day to submit applications to the #FDAInnovationChallenge is tomorrow, September 30th. Click the link to find out more about the challenge and how to submit your application:  https://go.usa.gov/xP4Nk pic.twitter.com/lLYiMa0cLe

Reminder: the last day to submit applications to the #FDAInnovationChallenge is tomorrow, September 30th. Click the link to find out more about the challenge and how to submit your application: https://go.usa.gov/xP4Nk pic.twitter.com/lLYiMa0cLe

Reminder: the last day to submit applications to the #FDAInnovationChallenge is tomorrow, September 30th. Click the link to find out more about the challenge and how to submit your application: https://go.usa.gov/xP4Nk  pic.twitter.com/lLYiMa0cLe

FDA - U.S. Food and Drug Administration

24-9-2018

#FDA announces the release of the Collaborative Communities Toolkit for interested stakeholder organizations to work together on healthcare challenges. Learn about the program, download the Toolkit, and submit comments:  https://go.usa.gov/xPjKX pic.twitt

#FDA announces the release of the Collaborative Communities Toolkit for interested stakeholder organizations to work together on healthcare challenges. Learn about the program, download the Toolkit, and submit comments: https://go.usa.gov/xPjKX pic.twitt

#FDA announces the release of the Collaborative Communities Toolkit for interested stakeholder organizations to work together on healthcare challenges. Learn about the program, download the Toolkit, and submit comments: https://go.usa.gov/xPjKX  pic.twitter.com/iQsKIAAQTn

FDA - U.S. Food and Drug Administration

24-9-2018

For more information about the #FDA’s effort to address the epidemic of  #opioid addiction, click the link to find out more about the  #FDAInnovationChallenge:  https://go.usa.gov/xPja7  The last day to submit  applications is September 30th, 2018.https:/

For more information about the #FDA’s effort to address the epidemic of #opioid addiction, click the link to find out more about the #FDAInnovationChallenge: https://go.usa.gov/xPja7  The last day to submit applications is September 30th, 2018.https:/

For more information about the #FDA’s effort to address the epidemic of #opioid addiction, click the link to find out more about the #FDAInnovationChallenge: https://go.usa.gov/xPja7  The last day to submit applications is September 30th, 2018. https://twitter.com/NIDAnews/status/1032719474934382593 …

FDA - U.S. Food and Drug Administration

18-9-2018

Thiogamma® 600 oral

Rote - Liste

17-9-2018

We had lots of great questions from potential applicants during our recent webinar. Check out the recording for Q&A about the #FDAInnovationChallenge. Click the link for the webinar recording:  https://go.usa.gov/xP4N5  #FDA #MedicalDevices

We had lots of great questions from potential applicants during our recent webinar. Check out the recording for Q&A about the #FDAInnovationChallenge. Click the link for the webinar recording: https://go.usa.gov/xP4N5  #FDA #MedicalDevices

We had lots of great questions from potential applicants during our recent webinar. Check out the recording for Q&A about the #FDAInnovationChallenge. Click the link for the webinar recording: https://go.usa.gov/xP4N5  #FDA #MedicalDevices

FDA - U.S. Food and Drug Administration

17-9-2018

The #FDAInnovationChallenge to develop medical devices for #opioid addiction will provide those selected with the opportunity to work directly with the agency to accelerate the development and review of their device proposals to prevent and treat opioid u

The #FDAInnovationChallenge to develop medical devices for #opioid addiction will provide those selected with the opportunity to work directly with the agency to accelerate the development and review of their device proposals to prevent and treat opioid u

The #FDAInnovationChallenge to develop medical devices for #opioid addiction will provide those selected with the opportunity to work directly with the agency to accelerate the development and review of their device proposals to prevent and treat opioid use disorder. #FDA

FDA - U.S. Food and Drug Administration

17-9-2018

Reminder: the FDA is accepting applications through Sept. 30, 2018, for the #FDAInnovationChallenge for devices to help combat #opioid addiction.   Submissions will be evaluated based on the feasibility, potential public health impact and novelty of the c

Reminder: the FDA is accepting applications through Sept. 30, 2018, for the #FDAInnovationChallenge for devices to help combat #opioid addiction. Submissions will be evaluated based on the feasibility, potential public health impact and novelty of the c

Reminder: the FDA is accepting applications through Sept. 30, 2018, for the #FDAInnovationChallenge for devices to help combat #opioid addiction. Submissions will be evaluated based on the feasibility, potential public health impact and novelty of the concept.

FDA - U.S. Food and Drug Administration

17-9-2018

 European Medicines Agency (EMA) Human Scientific Committees' Working Party with Healthcare Professionals’ Organisations (HCPWP), European Medicines Agency, London, UK, From: 26-Sep-2018, To: 26-Sep-2018

European Medicines Agency (EMA) Human Scientific Committees' Working Party with Healthcare Professionals’ Organisations (HCPWP), European Medicines Agency, London, UK, From: 26-Sep-2018, To: 26-Sep-2018

This Healthcare Professionals' Working Party (HCPWP) plenary meeting will include discussions on advances in clinical practice and the scientific and regulatory challenges. Members will also be invited to present how they are including regulatory sciences in fellowships and young researchers’ training. Feedback will be given from the representatives of the Scientific Committees.

Europe - EMA - European Medicines Agency

14-9-2018

Gabapentin AbZ 600 mg Filmtabletten

Rote - Liste

13-9-2018

 European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, From: 03-Dec-2018, To: 03-Dec-2018

European Medicines Agency stakeholder interaction on the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH), European Medicines Agency, London, UK, From: 03-Dec-2018, To: 03-Dec-2018

This workshop on the development of medicines for chronic non-infectious liver diseases, including primary biliary cholangitis, primary sclerosing cholangitis and nonalcoholic steatohepatitis, provides a platform for discussion on appropriate endpoints including validation of surrogate endpoints/biomarkers, suitable study populations, potentially adequate trial designs and the specific challenges with paediatric medicine development. The workshop will support the drafting of a reflection paper on regul...

Europe - EMA - European Medicines Agency

7-9-2018

 2018 Annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), European Medicines Agency, London, UK, From: 07-Jun-2018, To: 07-Jun-2018

2018 Annual workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA), European Medicines Agency, London, UK, From: 07-Jun-2018, To: 07-Jun-2018

Enpr-EMA will hold its tenth annual workshop on 7-8 June 2018 at EMA. The workshop brings relevant stakeholders together to discuss requirements, barriers and opportunities for the conduct of high-quality clinical studies in children. The overall theme of this year’s workshop will be a ‘holistic approach to paediatric research’. Highlights of this year’s workshop include: i) short perspectives of the various stakeholders involved in paediatric research (patient/young people advisory groups, research netw...

Europe - EMA - European Medicines Agency

24-8-2018

#OnePairTakeCare https://twitter.com/CDCgov/status/1032656962389913600 …

#OnePairTakeCare https://twitter.com/CDCgov/status/1032656962389913600 …

#OnePairTakeCare https://twitter.com/CDCgov/status/1032656962389913600 …

FDA - U.S. Food and Drug Administration

6-8-2018

Dolgit® 600

Rote - Liste

16-7-2018

On July 25th, the FDA will host a webinar to provide developers and interested applicants an opportunity to hear from the FDA and answer questions about the #FDAInnovationChallenge. Click the link for more information  http://go.usa.gov/xQvE9 pic.twitter.

On July 25th, the FDA will host a webinar to provide developers and interested applicants an opportunity to hear from the FDA and answer questions about the #FDAInnovationChallenge. Click the link for more information http://go.usa.gov/xQvE9 pic.twitter.

On July 25th, the FDA will host a webinar to provide developers and interested applicants an opportunity to hear from the FDA and answer questions about the #FDAInnovationChallenge. Click the link for more information http://go.usa.gov/xQvE9  pic.twitter.com/kT7EqyTPxr

FDA - U.S. Food and Drug Administration

29-6-2018

#FDAInnovationChallenge https://twitter.com/HHSGov/status/1012707386061012994 …

#FDAInnovationChallenge https://twitter.com/HHSGov/status/1012707386061012994 …

#FDAInnovationChallenge https://twitter.com/HHSGov/status/1012707386061012994 …

FDA - U.S. Food and Drug Administration

29-6-2018

#FDAInnovationChallenge https://twitter.com/SGottliebFDA/status/1012725536626536448 …

#FDAInnovationChallenge https://twitter.com/SGottliebFDA/status/1012725536626536448 …

#FDAInnovationChallenge https://twitter.com/SGottliebFDA/status/1012725536626536448 …

FDA - U.S. Food and Drug Administration

8-6-2018

#DYK Opioids are among the type of medication that are most commonly misused - https://go.usa.gov/xQ7Az  #FDAInnovationChallengepic.twitter.com/kQPmn4ezXD

#DYK Opioids are among the type of medication that are most commonly misused - https://go.usa.gov/xQ7Az  #FDAInnovationChallengepic.twitter.com/kQPmn4ezXD

#DYK Opioids are among the type of medication that are most commonly misused - https://go.usa.gov/xQ7Az  #FDAInnovationChallenge pic.twitter.com/kQPmn4ezXD

FDA - U.S. Food and Drug Administration

7-6-2018

Sobelin® Solubile 600

Rote - Liste

5-6-2018

#DYK The misuse of prescription drugs means taking a medication in a manner or dose other than prescribed; taking someone else’s prescription, even if for a legitimate medical complaint such as pain; or taking a medication to feel euphoria. #FDAInnovation

#DYK The misuse of prescription drugs means taking a medication in a manner or dose other than prescribed; taking someone else’s prescription, even if for a legitimate medical complaint such as pain; or taking a medication to feel euphoria. #FDAInnovation

#DYK The misuse of prescription drugs means taking a medication in a manner or dose other than prescribed; taking someone else’s prescription, even if for a legitimate medical complaint such as pain; or taking a medication to feel euphoria. #FDAInnovationChallenge pic.twitter.com/QI0mrJactV

FDA - U.S. Food and Drug Administration

1-6-2018

hydrocodone (Vicodin®), codeine, morphine, and many others. #DYK #FDAInnovationChallenge (2 of 2 messages)  https://go.usa.gov/xQwmW pic.twitter.com/bGlnTFOzVE

hydrocodone (Vicodin®), codeine, morphine, and many others. #DYK #FDAInnovationChallenge (2 of 2 messages) https://go.usa.gov/xQwmW pic.twitter.com/bGlnTFOzVE

hydrocodone (Vicodin®), codeine, morphine, and many others. #DYK #FDAInnovationChallenge (2 of 2 messages) https://go.usa.gov/xQwmW  pic.twitter.com/bGlnTFOzVE

FDA - U.S. Food and Drug Administration

1-6-2018

#DYK #Opioids are a type of drug that includes the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®) #FDAInnovationChallenge (1 of 2 messages)

#DYK #Opioids are a type of drug that includes the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®) #FDAInnovationChallenge (1 of 2 messages)

#DYK #Opioids are a type of drug that includes the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®) #FDAInnovationChallenge (1 of 2 messages)

FDA - U.S. Food and Drug Administration

30-5-2018

On July 25th, the FDA will host a webinar to provide developers and interested applicants an opportunity to hear from the FDA and answer questions about the #FDAInnovationChallenge. Click the link for more information  https://go.usa.gov/xQvE9 

On July 25th, the FDA will host a webinar to provide developers and interested applicants an opportunity to hear from the FDA and answer questions about the #FDAInnovationChallenge. Click the link for more information https://go.usa.gov/xQvE9 

On July 25th, the FDA will host a webinar to provide developers and interested applicants an opportunity to hear from the FDA and answer questions about the #FDAInnovationChallenge. Click the link for more information https://go.usa.gov/xQvE9 

FDA - U.S. Food and Drug Administration